EUVIMEDEUVIMED entdecken
Crossref

Synthesis of Radiolabeled and Stable‐Isotope Labeled Deucravacitinib (BMS‐986165)

John A Brailsford iD, Kai Cao iD, Samuel J Bonacorsi

Journal of Labelled Compounds and Radiopharmaceuticals · 2025

DOI: 10.1002/jlcr.4156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2025. Verfasst von John A Brailsford und 2 weiteren Autor:innen. Beteiligte Einrichtung: Discovery and Development Sciences - Radiochemistry, Bristol Myers Squibb, Princeton, New Jersey, USA. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors. Die Arbeit nennt 7 Literaturangaben. Gefördert von: Bristol Myers Squibb, Bristol-Myers Squibb Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deucravacitinib (BMS‐986165) is a small molecule allosteric inhibitor of tyrosine kinase 2 (TYK2) currently approved for the treatment of moderate to severe plaque psoriasis. Tyrosine kinase 2 (TYK2) is a member of the Janus (JAK) family of non‐receptor kinases that modulate the production of inflammatory cytokines. The synthesis of 14 C‐radiolabeled and stable‐isotope labeled variants of deucravacitinib is described in this publication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsIsotope LabelingChemistry Techniques, SyntheticCarbon Radioisotopes

Substanzen

Carbon RadioisotopesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Discovery and Development Sciences - Radiochemistry, Bristol Myers Squibb, Princeton, New Jersey, USA.

ORCID-Profile: John A Brailsford, Kai Cao

Förderung

  • Bristol Myers Squibb
  • Bristol-Myers Squibb Canada

Zitieren

APA

Brailsford, J. A., Cao, K., & Bonacorsi, S. J. (2025). Synthesis of Radiolabeled and Stable‐Isotope Labeled Deucravacitinib (BMS‐986165). Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4156

Vancouver

Brailsford JA, Cao K, Bonacorsi SJ. Synthesis of Radiolabeled and Stable‐Isotope Labeled Deucravacitinib (BMS‐986165). Journal of Labelled Compounds and Radiopharmaceuticals. 2025. doi:10.1002/jlcr.4156

BibTeX
@article{Brailsford2025,
  author = {Brailsford, John A and Cao, Kai and Bonacorsi, Samuel J},
  title = {Synthesis of Radiolabeled and Stable‐Isotope Labeled Deucravacitinib (BMS‐986165)},
  journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
  year = {2025},
  doi = {10.1002/jlcr.4156}
}
Kostenlos starten →